Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endozepines in recurrent stupor.

Pietro Cortelli1, Rossella Avallone, Mario Baraldi

  • 1Department of Neurological Sciences, University of Bologna, Via Ugo Foscolo, 7, 40123 Italy. pietro.cortelli@unibo.it

Sleep Medicine Reviews
|October 20, 2005
PubMed
Summary

Idiopathic recurrent stupor may be caused by endogenous benzodiazepine-like compounds (endozepines). Flumazenil, a benzodiazepine antagonist, reversed stupor, but the origin and mechanisms of endozepines remain unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. <i>Cells</i> 2025, <i>14</i>, 680.

Cells·2026
Same author

Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated <i>SOD1</i>-ALS: A Real-World Multicentre Cohort Study.

International journal of molecular sciences·2026
Same author

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study.

Expert opinion on biological therapy·2026
Same author

Green space exposure and risk of amyotrophic lateral sclerosis: a population-based case-control study in Northern Italy.

Environmental health : a global access science source·2026
Same author

Unilateral Primary Angiitis of the Central Nervous System (PACNS): a case report of unusual radiological presentation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World Study.

Journal of clinical medicine·2026

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Neurology

Background:

  • Stupor, often linked to diffuse cerebral dysfunction, can rarely be recurrent and idiopathic.
  • Endogenous benzodiazepine-like compounds (endozepines) have been proposed as a cause for idiopathic recurrent stupor.
  • Flumazenil, a benzodiazepine receptor antagonist, has shown efficacy in reversing stupor in affected patients.

Purpose of the Study:

  • To review the current understanding of endozepine physiology and pharmacology.
  • To discuss clinical syndromes associated with endozepine involvement.
  • To propose a diagnostic work-up for endozepine-induced recurrent stupor.

Main Methods:

  • Review of existing literature on endozepines, benzodiazepine receptors, and recurrent stupor.

Related Experiment Videos

  • Analysis of case studies where flumazenil was used to treat recurrent stupor.
  • Discussion of analytical challenges in detecting exogenous and endogenous benzodiazepines.

    • Main Results:

    • Endozepines are endogenous compounds acting on GABA(A) receptors, implicated in conditions like hepatic encephalopathy.
    • The precise origin, biosynthesis, and mechanisms of action of endozepines are not fully understood.
    • Detection of exogenous benzodiazepines can be challenging, raising questions about the validity of the endozepine concept in some recurrent stupor cases.

    Conclusions:

    • The concept of endozepine-induced recurrent stupor requires further investigation due to detection challenges and potential for fraudulent administration of benzodiazepines.
    • A structured diagnostic approach is needed to differentiate endozepine-mediated stupor from other causes.
    • Further research into endozepine biosynthesis and function is crucial for understanding and treating recurrent stupor.